Business
EU regulators reviewing J&J’s COVID vaccine after blood clots – Aljazeera.com
Johnson & Johnson is working with EU regulators to assess data on the rare clots, the company said in a statement.
The European Unions drug regulator has started a review to assess blood clots in people who received Johnson & Johnsons Covid-19 vaccine.
Four serious cases of unusual clots accompanied by low blood platelets, one of which was fatal, have emerged after immunization with the J&J shot, the European Medicines Agency said Friday. The regulator is now scrutinizing potential safety issues for two Covid vaccines, after AstraZeneca Plcs shot was possibly linked to a rare blood-clotting disorder.
J&J is…
-
General3 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News22 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General23 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Noosa News24 hours agoAppeal heard against sentences of teens who attacked Toutai Kefu and family in their Brisbane home